Latest news with #VELO
Cision Canada
5 days ago
- Business
- Cision Canada
Velo Protocol: Binance Alpha Listing Accelerates Asia's Web3 Liquidity Revolution
SINGAPORE, June 18, 2025 /CNW/ -- Velo Protocol (VELO), a pioneer of Web3 liquidity infrastructure in Asia, was listed on Binance Alpha on Monday, June 16, 2025. This listing not only increases $VELO's liquidity and connects its community to the global market, but also marks a strategic step in Velo Protocol's expansion roadmap to solidify its position as the backbone of Asia's digital financial ecosystem through significant milestones, an ambitious expansion roadmap, and visionary future project initiatives. In addition to the Binance Alpha Listing, The State of Velo Q1 2025 Report by Messari marks another important milestone for Velo Protocol. During Q1, average daily transactions surged 255.5%, rising from 445 to 1,581, driven by Nova network activity. Daily active addresses also increased 84.7%, from 2,363 to 4,364, while VELO-denominated TVL grew 10.1%. Backed by major institutions such as CP Group, UOB Venture Management, and HashKey, along with strategic collaborations with Paxos ($USDL) and Securitize to advance asset tokenization, Velo is building a compliant and scalable digital liquidity infrastructure across Asia. Unlocking New Financial Access in Asia Through its Universe and Orbit platforms, Velo has achieved multiple key milestones: Integration of the Lightyear Trading Bot with MT4, MT5, and Trading View, enhancing trading efficiency. SofinX-powered Social Trading feature that enables users to replicate top traders' strategies. Multi-chain support through integration with Solana and external wallets, expanding Universe DEX's reach. Omni Points loyalty program on Orbit delivering real multi-chain rewards. Surpassing 1 million Unique Active Wallets (UAW) on DAppRadar, signifying significant ecosystem growth. Major Expansion: Scaling Asia's Web3 Ecosystem With a vision to accelerate the transition from Web2 to Web3, Velo is introducing a series of innovations that significantly expand its ecosystem's capabilities. The Universe Platform will soon launch next-generation Multi FX and Perpetual (Perp) contracts, powered by a sophisticated Liquidity Aggregator that sources liquidity from multiple platforms. Meanwhile, the Profit-Sharing Social Trading feature enables users to benefit from automated trading bots or mirror the strategies of top-performing traders. To further enhance user experience, Multi-Chain & Wallet Connect integration allows seamless external wallet connectivity across multiple blockchains. Additionally, the Orbit Platform offers a Whitelabel Loyalty Platform, empowering businesses to adopt Web3-based loyalty programs with ease. Future Roadmap: Delivering Asia's Web3 Financial Infrastructure Collectively, these innovations serve as the foundation for Velo's long-term vision of building the Velo Financial Superhighway—a fully integrated Web3-native ecosystem aimed at driving financial inclusion across Asia. On the Liquidity Layer, Velo will feature the PLG Gold RWA Token for on-chain gold exposure, a Stable Coin and RWA Aggregator to strengthen trade stability, and a Web2 to Web3 Liquidity Backbone to bridge multi-chain liquidity. On the Wallet Layer, the Orbit-based Super Wallet will integrate payments and loyalty into a unified merchant ecosystem across Asia. On the Settlement Layer, Velo PAYFAI, an AI-based system that uses PayFi and AI agents to optimize settlement, will accelerate Web3-based cross-border trade financing, positioning Velo as a bridge asset in Asia's digital trade flows. The Binance Alpha listing and the Messari Report are not merely market expansion milestones, but a testament to the growing global confidence in Velo Protocol's technology, utility, and mission to bridge traditional and decentralized finance across Asia. This milestone further accelerates Velo Protocol's position as the backbone of Asia's liquidity infrastructure, powering the region's trillion-dollar digital economy. Velo Protocol is an Asia-based Web3 liquidity infrastructure bridging traditional and decentralized finance. With multi-chain technology, social trading, stablecoins, RWA, and AI-powered settlement, Velo is leading Asia's digital financial transformation. SOURCE Velo Labs Technology Ltd.
Business Upturn
06-06-2025
- Business
- Business Upturn
LEX Diagnostics Submits Dual Applications for FDA 510(k) Clearance and CLIA Waiver for Groundbreaking LEX VELO System
CAMBRIDGESHIRE, United Kingdom, June 06, 2025 (GLOBE NEWSWIRE) — LEX Diagnostics, a leading innovator in molecular diagnostics, has submitted dual applications to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance and CLIA waived status for its VELO system, an ultra-fast point-of-care molecular diagnostics platform designed to deliver highly sensitive PCR results for key respiratory pathogens directly from a swab sample in under ten minutes.1 The FDA submission represents a pivotal step in LEX Diagnostics' strategy and underscores the company's commitment to advancing point-of-care testing with accurate, timely, and clinically actionable results. 'This milestone reflects the strength of our R&D and clinical validation programs, as well as our broader mission to make molecular diagnostics faster, simpler, and more accessible,' said Ed Farrell, Chief Executive Officer of LEX Diagnostics. 'We believe the LEX VELO system will redefine point-of-care testing by equipping healthcare providers with lab-quality results in minutes, enabling faster clinical decisions and improved patient outcomes without compromising quality while improving workflow—an achievement that will set us apart in the marketplace.' The LEX system supports multiplex testing for key respiratory pathogens, including Influenza A, Influenza B, and COVID-19, and is engineered to deliver PCR results in six to ten minutes, easily integrating into clinical workflows across primary care settings, urgent care clinics, pharmacies, physician office laboratories and decentralized acute settings. Its proprietary cartridge-based design eliminates the need for external liquid handling, promoting ease of use and reliability. LEX recently completed clinical studies in the United States with the VELO system and the Influenza/Covid assay during the 2024/2025 respiratory season. LEX Diagnostics anticipates U.S. market clearance in late 2025 or early 2026, in alignment with expected FDA review timelines. About Lex Diagnostics LEX Diagnostics, a TTP Group Company, is a molecular diagnostics company transforming point-of-care testing through its proprietary ultra-fast thermal cycling technology. Designed to deliver lab-quality PCR results directly from a swab sample in minutes, the VELO system bridges the gap between accuracy and accessibility, empowering healthcare professionals to make informed clinical decisions faster. LEX Diagnostics is headquartered in Cambridgeshire, United Kingdom. Learn more at and follow us on LinkedIn. Forward-Looking Statements This press release contains forward-looking statements, including but not limited to, statements regarding product development, regulatory timelines, market potential, and expected outcomes. These statements are based on current assumptions and expectations that are subject to risks, uncertainties, and changes in circumstances. Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including regulatory decisions, market conditions, and operational challenges. LEX Diagnostics undertakes no obligation to update or revise any forward-looking statements made herein, except as required by law. Media Contacts LEX Diagnostics Chris Hole [email protected] Scius Communications Katja Stout+44 778 943 5990 [email protected]
Yahoo
06-06-2025
- Business
- Yahoo
LEX Diagnostics Submits Dual Applications for FDA 510(k) Clearance and CLIA Waiver for Groundbreaking LEX VELO System
CAMBRIDGESHIRE, United Kingdom, June 06, 2025 (GLOBE NEWSWIRE) -- LEX Diagnostics, a leading innovator in molecular diagnostics, has submitted dual applications to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance and CLIA waived status for its VELO system, an ultra-fast point-of-care molecular diagnostics platform designed to deliver highly sensitive PCR results for key respiratory pathogens directly from a swab sample in under ten minutes.1 The FDA submission represents a pivotal step in LEX Diagnostics' strategy and underscores the company's commitment to advancing point-of-care testing with accurate, timely, and clinically actionable results. 'This milestone reflects the strength of our R&D and clinical validation programs, as well as our broader mission to make molecular diagnostics faster, simpler, and more accessible,' said Ed Farrell, Chief Executive Officer of LEX Diagnostics. 'We believe the LEX VELO system will redefine point-of-care testing by equipping healthcare providers with lab-quality results in minutes, enabling faster clinical decisions and improved patient outcomes without compromising quality while improving workflow—an achievement that will set us apart in the marketplace.' The LEX system supports multiplex testing for key respiratory pathogens, including Influenza A, Influenza B, and COVID-19, and is engineered to deliver PCR results in six to ten minutes, easily integrating into clinical workflows across primary care settings, urgent care clinics, pharmacies, physician office laboratories and decentralized acute settings. Its proprietary cartridge-based design eliminates the need for external liquid handling, promoting ease of use and reliability. LEX recently completed clinical studies in the United States with the VELO system and the Influenza/Covid assay during the 2024/2025 respiratory season. LEX Diagnostics anticipates U.S. market clearance in late 2025 or early 2026, in alignment with expected FDA review timelines. About Lex Diagnostics LEX Diagnostics, a TTP Group Company, is a molecular diagnostics company transforming point-of-care testing through its proprietary ultra-fast thermal cycling technology. Designed to deliver lab-quality PCR results directly from a swab sample in minutes, the VELO system bridges the gap between accuracy and accessibility, empowering healthcare professionals to make informed clinical decisions faster. LEX Diagnostics is headquartered in Cambridgeshire, United Kingdom. Learn more at and follow us on LinkedIn. Forward-Looking Statements This press release contains forward-looking statements, including but not limited to, statements regarding product development, regulatory timelines, market potential, and expected outcomes. These statements are based on current assumptions and expectations that are subject to risks, uncertainties, and changes in circumstances. Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including regulatory decisions, market conditions, and operational challenges. LEX Diagnostics undertakes no obligation to update or revise any forward-looking statements made herein, except as required by law. Media Contacts LEX DiagnosticsChris Holeenquires@ Scius CommunicationsKatja Stout+44 778 943 5990katja@ Daniel Gooch+44 774 787 5479daniel@ _____________________1 This LEX Diagnostics product is currently under development and has not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority. It is not available for sale or distribution in the U.S., the U.K. or any other jurisdiction. All product descriptions, data, or discussions are preliminary, subject to change, and do not represent final or FDA-approved claims, indications, or labeling.
Gulf Today
28-05-2025
- Health
- Gulf Today
British American Tobacco Middle East DMCC (BAT) hosts Tobacco Harm Reduction event in Dubai
Gulf Network British American Tobacco Middle East DMCC hosted an event today in Dubai to spotlight the role of innovation and science in advancing tobacco harm reduction (THR). The event coincided with the release of the UAE's first national standards for tobacco-free oral nicotine pouches – marking a significant step in establishing a framework for product quality, safety, and manufacturing. At the event, BAT Middle East North Africa (MENA) highlighted its ongoing transformation toward building A Better Tomorrow, with a commitment to providing adult smokers, who would otherwise continue to smoke, with a wide range of reduced-risk* alternatives to combustible cigarettes. BAT also introduced Omni, its evidence-based, dynamic resource that showcases how science and innovation are driving progress towards A Smokeless World. Omni, a resource intended for scientists, public health authorities, regulators, policy makers, and investors, brings together hundreds of independent scientific studies and research, BAT's own research into its innovation, as well as real-world examples of Tobacco Harm Reduction (THR) in action. One of the real-world examples highlighted at the event was Sweden's success in achieving the lowest smoking prevalence in the European Union. A key to Sweden's success has been its openness to allow the sale of smokeless alternatives to cigarettes that satisfy adult smokers' desire for nicotine, and to avoid excessively restricting these products. Local insights shared at the event further underscored the growing consumer openness to smokeless products to combustible cigarettes in the UAE. According to local internal research conducted by Kantar, 83% of adult smokers in the UAE are open to switching to reduced-risk* alternatives. Commenting on the occasion, Alexandre Ghanem, General Manager of BAT MENA, said, 'We are proud to contribute to conversations that support science-led transformation in our industry. The availability of nicotine alternatives, supported by regulation, innovation, and evidence, is key to encouraging a complete switch among adult smokers who would otherwise continue smoking.' Showcasing Omni to the UAE audience for the first time, Mark Forster, BAT Group's Senior Scientific Engagement Manager, added: 'We believe that Tobacco Harm Reduction represents one of the most significant public health opportunities. Especially as we near World No Tobacco Day, we stand alongside those calling for well-thought-out regulations that can help countries achieve their smoke-free ambition by encouraging adult smokers, who would otherwise continue smoking, to switch completely to smokeless alternatives, while preventing underage use.' BAT's tobacco-free nicotine pouches are already available in over 40 countries. The company has plans to expand its smokeless product portfolio in the UAE under the flagship nicotine pouch brand VELO. *Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Scotsman
08-05-2025
- Business
- Scotsman
Nic Pouches launches customer loyalty rewards system
Nic Pouches, a UK-based online retailer specialising in tobacco-free nicotine alternatives, has introduced a new customer loyalty points system. Designed to reward returning shoppers, the scheme allows customers to accumulate points with every purchase, translating into discounts and special offers across the retailer's diverse nicotine pouch range. Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Nic Pouches, UK and Scotland based specialist retailer of tobacco-free nicotine products, has unveiled an innovative loyalty rewards programme aimed at enhancing customer retention and recognising repeat purchases. The newly introduced loyalty points system enables customers to earn points each time they shop, with accrued points convertible into discounts on future purchases. According to Nic Pouches, customers immediately gain 100 points upon signing up, kickstarting their rewards experience. Advertisement Hide Ad Advertisement Hide Ad Explaining the programme's tiered structure, a spokesperson for Nic Pouches stated: "Our Nic Pouches Loyalty Points Reward System ensures every purchase gets you closer to something extra. Rack up points as you shop and turn them into exclusive deals, discounts, and perks. It's our way of giving back to the ones who keep us going." Loyalty Has Its Rewards: Enjoy The Nic Pouches Special Offer! Customers progress through membership tiers as they accumulate points. The entry-level Blue membership provides a return of 2% of purchases as point-based credit, while Silver membership-achieved at 300 points-offers 4%. Gold membership, available after accumulating 1200 points, provides an 8% credit return, delivering sizable discounts for the retailer's most engaged customers. Nicotine pouches, which have surged in popularity as alternatives to traditional tobacco products, contain nicotine, flavourings, plant-based fibres, and food-grade sweeteners. They offer a cleaner, smoke-free route to nicotine consumption, absorbed by placing the pouch between gum and lip. This product range has attracted significant interest from health-aware consumers seeking an alternative to cigarette smoking. Nic Pouches hosts various industry-leading brands, such as VELO, Zyn, Pablo, Killa, and Nordic Spirit. Shoppers can choose from an extensive catalogue of flavours, including menthol, fruity varieties, coffee, and liquorice, catering to diverse customer tastes and preferences. Advertisement Hide Ad Advertisement Hide Ad The retailer highlights its strong commitment to quality control, ensuring products consistently deliver the appropriate nicotine dosage without the harmful effects associated with traditional smoking. Fast and reliable delivery throughout the UK further enhances its convenience appeal for customers. The retailer has emphasised a customer-centric approach through intuitive navigation of its online platform and rapid delivery times. A spokesperson explained: "Customer satisfaction is at the heart of everything we do. Our user-friendly website makes it easy to browse, select, and purchase your favourite nicotine pouches. Plus, our dedicated customer service team is always ready to assist you." In addition, a newsletter available through Nic Pouches informs customers about new product launches, exclusive deals, and nicotine pouch industry news, supporting a growing community of consumers exploring smoke-free options. Further independent analysis from tobacco and nicotine industry experts could provide additional insights into market trends and customer engagement results from similar loyalty programmes, adding context to Nic Pouches' new approach to consumer rewards. Advertisement Hide Ad Advertisement Hide Ad Nic Pouches has become an established online retailer of nicotine pouch products in the UK. Dedicated to providing convenient access to popular smoke-free nicotine alternatives, the Edgware, Middlesex-based company emphasises product quality, diverse selection, and exceptional customer service.
